Patrick Sung, D. Phil, Appointed as Director of the Greehey Children’s Cancer Research Institute at UT Health San Antonio.

Dr.-Patrick-Sung
Patrick Sung, DPhil, director of the Greehey Children’s Cancer Research Institute

We are pleased to announce the appointment of Patrick Sung, D. Phil, as director of the Greehey Children’s Cancer Research Institute (GCCRI) at UT Health San Antonio, effective March 1, 2022.

Dr. Sung currently serves as professor and interim chair of the Department of Biochemistry and Structural Biology and associate dean for research in the Joe R. and Teresa Lozano Long School of Medicine. In addition, Dr. Sung co-leads the Cancer Development and Progression Program at UT Health San Antonio’s Mays Cancer Center and holds the Robert A. Welch Distinguished Chair in Chemistry. He is a recipient of the Recruitment of Established Investigators Award from the Cancer Prevention and Research Institute of Texas (CPRIT) and the National Cancer Institute Outstanding Investigator R35 Award.

An internationally recognized leader in the mechanistic biochemistry of DNA repair, Dr. Sung established his independent research program in 1993. He has authored or coauthored 239 original research papers and his discoveries have increased our understanding of how DNA can repair damage induced by radiation, carcinogens, and other causes. Cancer cells are particularly reliant on DNA repair for survival. Hindering this capability is a major target for the development of therapeutics and Dr. Sung’s work.

As associate dean of research in the Long School of Medicine, Dr. Sung has successfully led the university’s efforts to secure CPRIT recruitment funding of $32 million over the last three years. He is an outstanding recruiter of faculty and a devoted mentor to many undergraduates, graduate students, and postdoctoral fellows as he prepares them for advanced careers in medicine and biomedical research. On the national level, he has served in many important leadership roles in science: as a member of three NIH study sections, as an NIH study section chair, and as a member of the National Advisory Environmental Health Sciences Council. He also has served as an associate editor of the Journal of Biological Chemistry since 2014.

Dr. Sung joined UT Health San Antonio from Yale University, where he was a professor of molecular biophysics and biochemistry and chair of the department. Prior to his time at Yale, he served as an assistant professor at The University of Texas Medical Branch in Galveston and as associate professor, professor, and deputy chair of the Department of Molecular Medicine here at UT Health San Antonio. He originally earned a Bachelor of Science degree at the University of Liverpool in 1981 and a Doctor of Philosophy degree at the University of Oxford in 1985. Both degrees are in biochemistry. He then completed postdoctoral fellowship training at the University of Rochester in the laboratories of Drs. Louise and Satya Prakash.

Dr. Sung’s scientific, administrative and mentoring expertise, coupled with his funding success, will enhance the outstanding scientific programs of the GCCRI. The GCCRI had been under the able leadership of Dr. Peter Houghton, who served as its director from December 2014 until the end of 2020. We owe Dr. Houghton a debt of gratitude for his service, which led to the establishment of the GCCRI as a national leader in pediatric oncology research. Dr. Manjeet Rao has been the interim director of the GCCRI since Dr. Houghton stepped down and we also thank him for his superb service. We owe thanks, as well, to Dr. Ruben Mesa and Dr. Houghton for leading the national search for this position.

Please join us in extending an enthusiastic welcome and best wishes for success to Dr. Sung in his new and important leadership position.

Sincerely,

William L. Henrich, MD, MACP

President and Professor of Medicine

and

Robert Hromas, MD, FACP

Dean, Joe R. and Teresa Lozano Long School of Medicine

Vice President for Medical Affairs


Since 2004, UT Health San Antonio, Greehey Children’s Cancer Research Institute’s (Greehey CCRI) mission has been to advance scientific knowledge relevant to childhood cancer, contribute to understanding its causes, and accelerate the translation of knowledge into novel therapies. Greehey CCRI strives to have a national and global impact on childhood cancer by discovering, developing, and disseminating new scientific knowledge. Our mission consists of three key areas — research, clinical, and education.

Stay connected with the Greehey CCRI on FacebookTwitterLinkedIn, and Instagram.

Article Categories: All News